“In Vivo Inhibitory Effect of Suberoylanilide Hydroxamic Acid Combined With Sorafenib on Human Hepatocellular Carcinoma Cells”. Brazilian Journal of Pharmaceutical Sciences, vol. 56, Dec. 2020, p. e18254, https://doi.org/10.1590/s2175-97902019000318254.